Warning: Undefined variable $count in /home/seniorca/public_html/wp-content/themes/divi-news-child-healthcare/index.php on line 40
Warning: Undefined variable $count in /home/seniorca/public_html/wp-content/themes/divi-news-child-healthcare/index.php on line 121
Artivion Closes Acquisition of Endospan Following FDA Approval of NEXUS Aortic Arch System
Artivion, Inc. has closed its acquisition of Endospan, an Israel-based developer of endovascular solutions for complex aortic arch disease. The deal, valued at $175 million less offsets for prior loans, includes up to an additional $200 million in contingent consideration based on U.S. commercial performance of the NEXUS system over the next two years. The transaction follows the FDA’s PMA approval of the NEXUS® Aortic Arch Stent-Graft System in April 2026. Endospan’s NEXUS is the first off-the-shelf endovascular stent-graft designed to treat aortic arch aneurysms and chronic dissections in patients at high risk for open surgery. The system is already commercially available in... Read More »
DC Advisory Works on Medical Device Transaction
DC Advisory reported that it worked on its third transaction of 2026. It advised The Carlyle Group on its acquisition of Hogy Medical Co. The acquisition was done through TCG2509 Corporation, a limited partnership wholly owned and managed by The Carlyle Group, established for the purpose of the acquisition. The deal is expected to close in May 2026. Hogy Medical Co is a Japanese manufacturer of medical-related products, including surgical kits. It is based in Toyko, Japan. The Carlyle Group is one of the world’s largest private equity firms. It manages more than $465 billion of assets under management, as of... Read More »
Medtronic to Acquire Scientia Vascular in 2nd Deal of 2026
On March 10, Medtronic announced its entry into a definitive agreement to acquire Scientia Vascular. The acquisition is valued at $550 million, subject to customary adjustments, with potential undisclosed earn-out and milestone payments post-acquisition. Scientia Vascular is a private company operating in Salt Lake City, Utah, with approximately 310 employees. The company has developed access products that enable simplicity and access for physicians treating complex neurovascular conditions. Medtronic manufactures and sells device-based medical therapies worldwide, including spinal, cardiovascular and minimally invasive devices. For the fiscal year (FY) ending April 25, 2025, the company... Read More »
Tactile Systems Technology Buys LymphaTech for $6.8 Million Upfront
Tactile Systems Technology, Inc. announced that it is acquiring LymphaTech for an upfront cash payment at closing of $6.8 million, plus potential additional consideration that is contingent upon the achievement of future milestones. Founded in 2014, LymphaTech is a privately held medical technology company pioneering a digital, three-dimensional full body measurement and monitoring platform designed specifically for lymphedema. Tactile Systems Technology is a medical technology company focused on developing medical devices for the treatment of underserved chronic diseases at home. The company develops and markets at-home therapies for people suffering from underserved, chronic conditions,... Read More »
